Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19)

doi:10.1016/j.jointm.2022.07.001

. 2022 Aug 26;2(4):199-222.

doi: 10.1016/j.jointm.2022.07.001. eCollection 2022 Oct.

Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19)

You Shang¹, Jianfeng Wu², Jinglun Liu³, Yun Long⁴, Jianfeng Xie⁵, Dong Zhang⁶, Bo Hu⁷, Yuan Zong⁸, Xuelian Liao⁹, Xiuling Shang¹⁰, Renyu Ding¹¹, Kai Kang¹², Jiao Liu¹³, Aijun Pan¹⁴, Yonghao Xu¹⁵, Changsong Wang¹⁶, Qianghong Xu¹⁷, Xijing Zhang¹⁸, Jicheng Zhang¹⁹, Ling Liu⁵, Jiancheng Zhang¹, Yi Yang⁵, Kaijiang Yu¹², Xiangdong Guan², Dechang Chen¹³; Chinese Society of Critical Care Medicine, Chinese Medical Association

Affiliations

¹ Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.
² Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510010, China.
³ Department of Emergency and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
⁴ Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100730, China.
⁵ Department of Critical Care Medicine, Jiangsu Provincial Key Laboratory of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.
⁶ Department of Critical Care Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
⁷ Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
⁸ Department of Critical Care Medicine, Shaanxi Provincial Hospital, Xi'an, Shannxi 710068, China.
⁹ Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
¹⁰ Department of Critical Care Medicine, Fujian Provincial Hospital, Fujian Provincial Center for Critical Care Medicine, Fuzhou, Fujian 350001, China.
¹¹ Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
¹² Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
¹³ Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
¹⁴ Department of Critical Care Medicine, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.
¹⁵ Department of Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
¹⁶ Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150001, China.
¹⁷ Department of Critical Care Medicine, Zhejiang Hospital Affiliated to Medical College of Zhejiang University, Hangzhou, Zhejiang 310013, China.
¹⁸ Department of Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shannxi 710032, China.
¹⁹ Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.

PMID: 36785648
PMCID: PMC9411033
DOI: 10.1016/j.jointm.2022.07.001

Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19)

You Shang et al. J Intensive Med. 2022.

. 2022 Aug 26;2(4):199-222.

doi: 10.1016/j.jointm.2022.07.001. eCollection 2022 Oct.

Authors

Affiliations

¹ Department of Critical Care Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, Hubei 430022, China.
² Department of Critical Care Medicine, The First Affiliated Hospital of Sun Yat-Sen University, Guangzhou, Guangdong 510010, China.
³ Department of Emergency and Critical Care Medicine, The First Affiliated Hospital of Chongqing Medical University, Chongqing 400016, China.
⁴ Department of Critical Care Medicine, Peking Union Medical College Hospital, Peking Union Medical College, Chinese Academy of Medical Science, Beijing 100730, China.
⁵ Department of Critical Care Medicine, Jiangsu Provincial Key Laboratory of Critical Care Medicine, Zhongda Hospital, School of Medicine, Southeast University, Nanjing, Jiangsu 210009, China.
⁶ Department of Critical Care Medicine, The First Hospital of Jilin University, Changchun, Jilin 130021, China.
⁷ Department of Critical Care Medicine, Zhongnan Hospital of Wuhan University, Wuhan, Hubei 430071, China.
⁸ Department of Critical Care Medicine, Shaanxi Provincial Hospital, Xi'an, Shannxi 710068, China.
⁹ Department of Critical Care Medicine, West China Hospital, Sichuan University, Chengdu, Sichuan 610041, China.
¹⁰ Department of Critical Care Medicine, Fujian Provincial Hospital, Fujian Provincial Center for Critical Care Medicine, Fuzhou, Fujian 350001, China.
¹¹ Department of Critical Care Medicine, The First Hospital of China Medical University, Shenyang, Liaoning 110001, China.
¹² Department of Critical Care Medicine, The First Affiliated Hospital of Harbin Medical University, Harbin, Heilongjiang 150001, China.
¹³ Department of Critical Care Medicine, Ruijin Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai 200025, China.
¹⁴ Department of Critical Care Medicine, The First Affiliated Hospital of USTC, Division of Life Science and Medicine, University of Science and Technology of China, Hefei, Anhui 230001, China.
¹⁵ Department of Critical Care Medicine, The First Affiliated Hospital of Guangzhou Medical University, Guangzhou, Guangdong 510120, China.
¹⁶ Department of Critical Care Medicine, Harbin Medical University Cancer Hospital, Harbin, Heilongjiang 150001, China.
¹⁷ Department of Critical Care Medicine, Zhejiang Hospital Affiliated to Medical College of Zhejiang University, Hangzhou, Zhejiang 310013, China.
¹⁸ Department of Critical Care Medicine, Xijing Hospital, Fourth Military Medical University, Xi'an, Shannxi 710032, China.
¹⁹ Department of Critical Care Medicine, Shandong Provincial Hospital Affiliated to Shandong First Medical University, Jinan, Shandong 250021, China.

PMID: 36785648
PMCID: PMC9411033
DOI: 10.1016/j.jointm.2022.07.001

No abstract available

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Cited by

Efficacy and safety of proxalutamide (GT0918) in severe or critically ill patients with COVID-19: study protocol for a prospective, open-label, single-arm, single-center exploratory trial.
Yang D, Ju M, Wang H, Jia Y, Wang X, Fang H, Fan J. Yang D, et al. BMC Pharmacol Toxicol. 2023 Jun 15;24(1):38. doi: 10.1186/s40360-023-00678-7. BMC Pharmacol Toxicol. 2023. PMID: 37322522 Free PMC article.
Herbal and Dietary Supplements as Adjunctive Treatment for Mild SARS-CoV-2 Infection in Italy.
Licata A, Seidita A, Como S, de Carlo G, Cammilleri M, Bonica R, Soresi M, Veronese N, Chianetta R, Citarrella R, Giannitrapani L, Barbagallo M. Licata A, et al. Nutrients. 2025 Jan 9;17(2):230. doi: 10.3390/nu17020230. Nutrients. 2025. PMID: 39861359 Free PMC article. Review.

References

1. Lamers M.M., Haagmans B.L. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270–284. doi: 10.1038/s41579-022-00713-0. - DOI - PubMed
1. World Health Organization (WHO) World Health Organization (WHO); 2021. WHO coronavirus (COVID-19) dashboard.https://covid19.who.int/ Available from: [Last accessed on July 2...2022]
1. Kadri S.S., Simpson S.Q. Potential implications of SARS-CoV-2 delta variant surges for rural areas and hospitals. JAMA. 2021;326(11):1003–1004. doi: 10.1001/jama.2021.13941. - DOI - PubMed
1. Pérez-Then E., Lucas C., Monteiro V.S., Miric M., Brache V., Cochon L., et al. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nat Med. 2022;28(3):481–485. doi: 10.1038/s41591-022-01705-6. - DOI - PMC - PubMed
1. Callaway E., Ledford H. How bad is Omicron? What scientists know so far. Nature. 2021;600(7888):197–199. doi: 10.1038/d41586-021-03614-z. - DOI - PubMed

LinkOut - more resources

Full Text Sources

[1] Lamers M.M., Haagmans B.L. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270–284. doi: 10.1038/s41579-022-00713-0. - DOI - PubMed

[2] Lamers M.M., Haagmans B.L. SARS-CoV-2 pathogenesis. Nat Rev Microbiol. 2022;20(5):270–284. doi: 10.1038/s41579-022-00713-0. - DOI - PubMed

[3] World Health Organization (WHO) World Health Organization (WHO); 2021. WHO coronavirus (COVID-19) dashboard.https://covid19.who.int/ Available from: [Last accessed on July 2...2022]

[4] World Health Organization (WHO) World Health Organization (WHO); 2021. WHO coronavirus (COVID-19) dashboard.https://covid19.who.int/ Available from: [Last accessed on July 2...2022]

[5] Kadri S.S., Simpson S.Q. Potential implications of SARS-CoV-2 delta variant surges for rural areas and hospitals. JAMA. 2021;326(11):1003–1004. doi: 10.1001/jama.2021.13941. - DOI - PubMed

[6] Kadri S.S., Simpson S.Q. Potential implications of SARS-CoV-2 delta variant surges for rural areas and hospitals. JAMA. 2021;326(11):1003–1004. doi: 10.1001/jama.2021.13941. - DOI - PubMed

[7] Pérez-Then E., Lucas C., Monteiro V.S., Miric M., Brache V., Cochon L., et al. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nat Med. 2022;28(3):481–485. doi: 10.1038/s41591-022-01705-6. - DOI - PMC - PubMed

[8] Pérez-Then E., Lucas C., Monteiro V.S., Miric M., Brache V., Cochon L., et al. Neutralizing antibodies against the SARS-CoV-2 Delta and Omicron variants following heterologous CoronaVac plus BNT162b2 booster vaccination. Nat Med. 2022;28(3):481–485. doi: 10.1038/s41591-022-01705-6. - DOI - PMC - PubMed

[9] Callaway E., Ledford H. How bad is Omicron? What scientists know so far. Nature. 2021;600(7888):197–199. doi: 10.1038/d41586-021-03614-z. - DOI - PubMed

[10] Callaway E., Ledford H. How bad is Omicron? What scientists know so far. Nature. 2021;600(7888):197–199. doi: 10.1038/d41586-021-03614-z. - DOI - PubMed

Save citation to file

Email citation

Add to Collections

Add to My Bibliography

Your saved search

Create a file for external citation management software

Your RSS Feed

Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19)

Affiliations

Expert consensus on the diagnosis and treatment of severe and critical coronavirus disease 2019 (COVID-19)

Authors

Affiliations

Conflict of interest statement

Similar articles

Cited by

References

LinkOut - more resources

Full Text Sources